This inventor holds 5 USPTO granted patents. Top assignee: Astrazeneca Ab. Active years: 2001-2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001-2005
Title: Ann Charlotte Birgit Johansson: Innovator in Therapeutic Administration
Introduction
Ann Charlotte Birgit Johansson is a prominent inventor based in Lund, Sweden. She has made significant contributions to the field of therapeutic preparations, particularly in the administration of insulin treatments. With a total of 5 patents to her name, Johansson's work has the potential to improve the quality of life for many patients requiring insulin therapy.
Latest Patents
Among her latest patents is a groundbreaking method for systemic administration of a therapeutic preparation. This method involves treating patients in need of insulin by introducing an effective amount of a dry powder containing insulin and an enhancer compound into the lower respiratory tract. This innovative approach aims to enhance the absorption of insulin in the lungs, providing a more efficient treatment option. Another notable patent focuses on dry powder compositions suitable for inhalation. These compositions comprise a pharmacologically active polypeptide and a surfactant, with at least 50% of the total mass consisting of primary particles having a diameter of less than 10 microns. This formulation is designed for use with dry powder inhaler devices, further advancing the field of inhalation therapies.
Career Highlights
Johansson's career is marked by her dedication to research and development in the pharmaceutical industry. She is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. Her work at AstraZeneca has allowed her to explore innovative solutions for drug delivery and patient care.
Collaborations
Throughout her career, Johansson has collaborated with esteemed colleagues, including Peter Edman and Kjell Göran Erik Bäckström. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in therapeutic technologies.
Conclusion
Ann Charlotte Birgit Johansson's contributions to the field of therapeutic administration exemplify her commitment to innovation and patient care. Her patents and ongoing work continue to pave the way for advancements in insulin treatment and inhalation therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile